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ABSTRACT Disease resistance in plants is often con-
trolled by a gene-for-gene mechanism in which avirulence
(avr) gene products encoded by pathogens are specifically
recognized, either directly or indirectly, by plant disease
resistance (R) gene products. Members of the NBS-LRR class
of R genes encode proteins containing a putative nucleotide
binding site (NBS) and carboxyl-terminal leucine-rich repeats
(LRRs). Generally, NBS-LRR proteins do not contain pre-
dicted transmembrane segments or signal peptides, suggest-
ing they are soluble cytoplasmic proteins. RPM1 is an NBS-
LRR protein from Arabidopsis thaliana that confers resistance
to Pseudomonas syringae expressing either avrRpm1 or avrB.
RPM1 protein was localized by using an epitope tag. In
contrast to previous suggestions, RPM1 is a peripheral mem-
brane protein that likely resides on the cytoplasmic face of the
plasma membrane. Furthermore, RPM1 is degraded coinci-
dent with the onset of the hypersensitive response, suggesting
a negative feedback loop controlling the extent of cell death
and overall resistance response at the site of infection.
Disease resistance in plants often hinges on the ability of the
host to recognize specific avirulence (avr) determinants pre-
sented by invading microorganisms. This recognition event is
controlled by plant disease resistance (R) genes, which are
proposed to act as receptors for specific avr-encoded deter-
minants (1). Avr recognition by the plant initiates an elaborate
defense response including changes in membrane ion flux, the
production of extracellular reactive oxygen intermediates,
irreversible plasma membrane (PM) damage, and changes in
gene expression and metabolite production (2). This set of
responses typically includes localized cell death at the site of
pathogen infection, termed the hypersensitive response (HR).
In the absence of either R or avr gene, no recognition occurs
and the pathogen is able to colonize the host and cause disease.
R genes can be classified by the putative motifs contained in
the proteins they encode (1). The largest class encodes a
centrally located nucleotide binding site (NBS) and a carboxyl-
terminal block of leucine-rich repeats (LRRs). NBS-LRR
genes conferring resistance to a number of bacterial, fungal,
and viral pathogens have been cloned from a variety of plant
species, suggesting that the general NBS-LRR structure is well
adapted to recognize a wide range of signals. Subclassification
of NBS-LRR sequences is based on the N-terminal domain,
which contains either a leucine zipper (LZ) motif or homology
with the cytoplasmic domains of the Toll and interleukin-1
receptors (TIR) domain. Computer analysis of predicted NBS-
LRR proteins has failed to identify likely transmembrane
segments. A potential exception was the prediction of a
putative single-pass transmembrane domain in the RPS2 pro-
tein. However, site-directed alteration of this sequence to one
not predicted to be membrane associated had no effect on
RPS2 function (3). Furthermore, with the exception of the
predicted flax L6 protein (4), none appear to contain a signal
peptide. This led to the hypothesis that NBS-LRR proteins are
soluble in the cytoplasm. This predicted localization is con-
sistent with recent findings that suggest that several avr-
encoded proteins produced by extracellular pathogens act
inside the host cell (3, 5, 6). Delivery of these molecules, in the
case of phytopathogenic bacteria such as Pseudomonas syrin-
gae and Xanthomonas campestris, requires the evolutionarily
conserved type III secretion machinery encoded in plant
pathogens by hrp (hypersensitivity and pathogenicity) genes
(7).
Whereas there is a growing body of literature regarding the
identification of new R gene sequences and the evolution of R
gene families, very little is known about the corresponding
proteins and the role they play in signal perception and
transduction. We are characterizing the product of the Arabi-
dopsis thaliana RPM1 gene. RPM1 encodes an LZ-NBS-LRR
protein and confers resistance to the bacterial pathogen P.
syringae expressing either of two sequence-unrelated avr genes,
avrRpm1 or avrB (8). Using an epitope-tagging strategy, we
identified the RPM1 protein in whole plant extracts. In
contrast to previous computer-based suggestions for this class
of R protein (9), we found RPM1 to be membrane associated
and highly enriched in PMfractions. In addition, RPM1 is
rapidly degraded at the onset of the HR, perhaps revealing a
negative feedback loop that functions to limit the extent of the
cell death and the amplitude of the overall disease resistance
response.
MATERIALS AND METHODS
Vector Construction and Plant Transformation. The 39 end
of the RPM1 coding region was PCR amplified with one primer
(59-GCC GCT CGA GAT GAG AGG AAT TAC GG-39)
designed to replace the endogenous translational stop codon
with an XhoI site and a second primer (59-ACA ATG GAG
AAT TAC GGT-39) that annealed upstream of the unique
XbaI site in the coding region. The resulting amplification
product was cleaved with XbaI and XhoI and used to replace
the corresponding portion of the wild-type RPM1 gene. The
carboxyl-terminal XhoI site was then ligated to the SalI site of
plasmid #CD3–128 (Arabidopsis Biological Resource Center,
The publication costs of this article were defrayed in part by page charge
payment. This article must therefore be hereby marked ‘‘advertisement’’ in
accordance with 18 U.S.C. §1734 solely to indicate this fact.
© 1998 by The National Academy of Sciences 0027-8424y98y9515849-6$2.00y0
PNAS is available online at www.pnas.org.
This paper was submitted directly (Track II) to the Proceedings office.
Abbreviations: avr, avirulence; hpi, hours postinoculation; HR, hy-
persensitive response; LRR, leucine-rich repeat; LZ, leucine zipper;
NBS, nucleotide binding site; ER, endoplasmic reticulum; PM, plasma
membrane; TIR, Tollyinterleukin-1 receptor homology.
†Current Address: Paradigm Genetics, Inc., 104 Alexander Drive,
Building 2, P.O. Box 14528, Research Triangle Park, NC 27709-4528.
§To whom reprint requests should be addressed. e-mail: dangl@email.
unc.edu.
15849
Ohio State University, Columbus, OH), thus creating a car-
boxyl-terminal translational fusion with five complete and one
partial tandem repeats of the c-Myc epitope (MEQKLISEED-
LNE; ref. 10). The chimeric RPM1::MYC gene, including 1,034
bp of promoter sequence upstream of the translational start
codon, was subcloned into a binary vector derived from
pGPTV-HPT (11), electroporated into Agrobacterium strain
GV3101(pMP90) and transformed by vacuum infiltration (12)
into plants.
Plant Growth and P. syringae Infection. The rps3–1 mutant
is a frameshift allele of RPM1 in the Col-0 background referred
to henceforth as rpm1-fs (8, 13). Plant growth conditions were
described previously (14). DC3000 and the avr-expressing
plasmids in pVSP61 have been described (8, 13). P. syringae
strains were grown overnight in King’s B medium (14) with
appropriate antibiotics, washed once in 10 mM MgCl2 and
resuspended to a density of '5 3 107 cfuyml for HR tests and
RPM1::MYC expression analysis. A density of '5.5 3 103
cfuyml was used for analysis of in planta growth. Bacterial
suspensions were pressure infiltrated into the abaxial leaf
surface by using a needleless 1-ml disposable syringe (14).
Antibody Production, Immunoprecipitation, and Protein
Blot Analysis. RPM1 fragments containing the NBS (aa
177–458) and LRR (aa 536–926) domains (Fig. 1A) were
amplified by PCR and cloned into the XhoIyBamHI sites of
pET14b (Novagen) to create translational fusions with an
N-terminal His6 tag. Fusion proteins were isolated from
Escherichia coli as insoluble inclusion bodies, purified by
preparative SDSyPAGE and transferred to nitrocellulose fil-
ters. Strips of nitrocellulose-bound antigen were solubilized
with dimethyl sulfoxide and injected into goats to produce
anti-NBS and anti-LRR polyclonal antisera. The anti-c-Myc
monoclonal antibody was isolated from hybridoma line 9E10
culture supernatant (University of North Carolina Lineberger
Tissue Culture Facility, Chapel Hill, NC).
Extracts for immunoprecipitation were prepared by grinding
'200 mg leaf tissue in 500 ml ice-cold extraction buffer (20 mM
TriszHCl (pH 7.5)y1 mM EDTAy150 mM NaCly1% (volyvol)
TX-100). Cell debris was removed by centrifugation at
13,000 3 g for 20 min and soluble protein remaining in the
supernatant was quantitated by using the DC protein assay
(Bio-Rad). For immunoprecipitations, '500 mg extract (in a
volume of 500 ml) was combined with 5 ml crude anti-RPM1
antisera or 20 ml purified 9E10 anti-myc monoclonal antibody
and rotated end-over-end at 4°C for 1 hr. Protein G-agarose
beads (30 ml; Boehringer Mannheim) were added and the
incubation was continued for 1 hr. Immuno-complexes were
washed four times with 1 ml ice-cold extraction buffer, resus-
pended in 20 ml SDSyPAGE sample buffer, heated to 70°C for
5 min and analyzed by SDSyPAGE, as given below. Extracts
for standard protein blot analysis were prepared in the above
extraction buffer with the addition of 0.1% (wtyvol) SDS and
5 mM DTT. Approximately 30 mg of protein was loaded per
lane of a 7.5% SDSyPAGE gel. Proteins were electroblotted
to nitrocellulose membranes and blocked for 1 hr in TBST (20
mM TriszHCl (pH7.6)y130 mM NaCly0.05% (volyvol) Tween-
20) containing 5% (wtyvol) nonfat dry milk. Reaction with
primary antibodies was carried out for 1 hr at room temper-
ature with 1% (wtyvol) nonfat dry milk in TBST. For anti-c-
Myc reactions, undiluted 9E10 tissue culture supernatant was
used. Horseradish peroxidase-conjugated secondary antibod-
ies (Amersham) were diluted 1:2,000 in TBST containing 1%
(wtyvol) nonfat dry milk and reacted with the blots for 1 hr at
room temperature. Bands were visualized by using the ECL kit
(Amersham).
Membrane Fractionation. Tissue was homogenized on ice in
lysis buffer (0.33 M sucrosey20 mM TriszHCl (pH 7.5)y1 mM
EDTAy2 mgyml aprotininy2 mg/ml leupeptiny1 mg/ml pepsta-
tin A) by using a Waring blender and polytron. The lysate was
cleared of cell-wall debris, nuclei, and intact organelles by
filtration through micracloth and centrifugation at 2,000 3 g
FIG. 1. Structure, function, and immunodetection of RPM1::MYC. (A) The deduced RPM1 protein indicating the position of the leucine zipper
(L-ZIP), putative NBS, and LRR domains. GLPL denotes the core of a conserved sequence motif of unknown function found in all NBS-LRR
proteins. Vertical ticks occur every 100 aa. Bars below the schematic define the regions of the protein used to generate the anti-NBS and anti-LRR
polyclonal antisera. (B) Complementation of the rpm1-fs mutation with RPM1::MYC. Bacterial growth in leaves infiltrated with DC3000(avrRpm1)
at a density of '5.5 3 103 cfuycm2 was assayed 72 hpi. In planta bacterial titers are given for nontransformed rpm1-fs, wild-type Col-0, and five
independent rpm1-fs (RPM1::MYC) transgenic lines. (C) Immunodetection of RPM1::MYC by using monoclonal anti-c-Myc antibody after
immunoprecipitation with either anti-LRR antisera or monoclonal anti-c-Myc antibody. C is extract from nontransformed control plants, T from
transgenic #4 of B. Anti-mouse IgG second step antibody detects the IgG heavy (IgH) and light (IgL) chains of the monoclonal.
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for 10 min. Centrifugation at 100,000 3 g for 1 hr generated
crude soluble (supernatant) and microsomal membrane (pel-
let) fractions. Linear and step sucrose gradients were as
described (15). Aqueous two-phase partitioning to enrich for
PMvesicles was also as described (16), with a polymer con-
centration of 6.2% (wtyvol).
RESULTS
Identification of the RPM1 Protein in Plant Extracts. Our
strategy to detect RPM1 in plant extracts used polyclonal
antibodies raised against two nonoverlapping domains of
RPM1, designated NBS and LRR, as well as transgenic plants
expressing an RPM1 protein modified by the addition of a
carboxyl-terminal c-Myc epitope tag (Fig. 1 A). The native
RPM1 transcript is present at very low levels (8), suggesting
that its protein product may be rare as well. We were therefore
concerned that overexpression of the RPM1::MYC protein in
transgenic plants might alter or obscure its normal subcellular
localization. Thus, to most closely reflect the endogenous
RPM1 expression level, transcription of the RPM1::MYC con-
struct was driven by '1 kb of the native RPM1 promoter.
The carboxyl-terminal epitope-tagged RPM1 protein re-
stored wild-type levels of resistance when transformed into the
rpm1-fs mutant line (Fig. 1B), which contains a frame-shift
mutation within the RPM1 coding region and is a loss-of-
function mutant when challenged with DC3000(avrRpm1) (8,
13). Of 12 transgenic T2 lines assayed, 10 responded to
high-dose (5 3 107 cfuyml) inoculation with
DC3000(avrRpm1) by generating a characteristic HR '5 hr
postinoculation [hours postinoculation (hpi); data not shown].
Furthermore, five of these lines were analyzed for the ability
to restrict the growth of DC3000(avrRpm1) in planta. All five
displayed an approximate two-log reduction in bacterial
growth 3 days postinoculation relative to nontransformed
control rpm1-fs plants (Fig. 1B). Both the timing of HR (not
shown) and the reduction in growth are comparable to that
seen in wild-type RPM1 backgrounds (e.g., Col-0; Fig. 1B).
From this functional analysis, we conclude that the subcellular
localization of the epitope-tagged RPM1 protein should
closely parallel that of the endogenous RPM1 protein.
Immunoprecipitation of RPM1::MYC protein with the anti-
LRR antisera followed by detection on protein blots with the
anti-c-Myc antibody revealed a strong band at the predicted
size of 117 kDa (Fig. 1C Left). No signal of the expected size
was observed in immunoprecipitations from nontransformed
control plants (Fig. 1C). Similar results were obtained with the
anti-NBS antisera (not shown). We additionally immunopre-
cipitated and subsequently detected RPM1::MYC directly
using the anti-c-Myc monoclonal antibody (Fig. 1C Right).
Thus, the 117-kDa protein is recognized by two distinct
anti-RPM1 antibodies and by the anti-c-Myc antibody as well,
clearly defining it as the RPM1::MYC protein. Unexpectedly,
neither anti-RPM1 antisera detected endogenous RPM1 or
RPM1::MYC protein on blots of denatured total protein
extracts (data not shown). This lack of detection prevented
localization of the native RPM1 protein.
RPM1::MYC Is Peripherally Associated with the Plasma
Membrane. We directly detected RPM1::MYC routinely on
blots of total protein extracts using the anti-c-Myc antibody.
Fig. 2A displays a comparison of three independent transgenic
lines that express the RPM1::MYC protein. In each case, the
FIG. 2. RPM1::MYC is a peripheral PM protein. (A) Protein blot of total (T), soluble (S), and microsomal membrane (M) fractions from
nontransformed rpm1-fs control plants and three rpm1-fs (RPM1::MYC) transgenic lines reacted with the anti-c-Myc monoclonal antibody. Equal
amounts of protein were loaded in each lane. Arrowhead indicates the position of RPM1::MYC. Anti-c-Myc crossreacting bands at '98 and '150
Kd were present in nontransformed control lines. (B) Protein blot reacted with the anti-c-Myc monoclonal antibody demonstrating peripheral
association of RPM1::MYC with the membrane. Total extract (T) was centrifuged at 100,000 3 g to generate soluble (S) and microsomal membrane
fractions. Membranes were treated as specified to release peripheral membrane proteins. Remaining membranes were pelleted and the newly soluble
proteins were analyzed. (C) Fractionation of RPM1::MYC on sucrose gradients. A 12–55% (wtyvol) linear sucrose gradient was used to fractionate
total extract from transgenic plants. Aliquots of each fraction were blotted to nitrocellulose and were analyzed with either anti-c-Myc or the
subcellular compartment marker antibodies listed at the right of each panel. (D) Protein blot analysis of membranes fractions obtained by aqueous
two-phase partitioning. Total extract (T), intracellular membrane (I), and plasma membrane (P) vesicle fractions were separated by SDSyPAGE,
transferred to nitrocellulose and reacted sequentially with antibodies against the c-Myc epitope, RD28, g-TIP, and BiP.
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expected band of 117 kDa is present in the total extract (Fig.
2A). Isolation of crude soluble and microsomal membrane
fractions by centrifugation at 100,000 3 g revealed that
RPM1::MYC was contained completely in the membrane
pellet in all three lines examined (Fig. 2A). Two other bands
can be seen at '98 (variably detected) and '150 kDa. These
bands are also present in nontransformed control extracts and
therefore correspond to endogenous proteins that crossreact
with the anti-c-Myc monoclonal antibody (Fig. 2 A). In addi-
tion, neither of these bands is detected on anti-c-Myc protein
blots of immunoprecipitated RPM1::MYC (Fig. 1).
Because RPM1 lacks an obvious transmembrane segment,
we reasoned that peripheral association with the membrane
fraction was likely. As expected, treatment of microsomal
membranes with detergents such as 1% (volyvol) Triton X-100
solubilized the microsomal membrane pellet and released
RPM::MYC (Fig. 2B). Treatment of microsomal membranes
with 100 mM sodium carbonate or 2 M urea also removed
RPM::MYC from the membrane (Fig. 2B). These treatments
do little damage to the integrity of the lipid bilayer and integral
proteins, but are known to release many peripheral proteins
(17). Indeed, even the physical force of resuspending the
membrane pellet in extraction buffer was sufficient to release
a portion of the RPM::MYC protein from the membrane
fraction (Fig. 2B). Thus, we conclude that RPM1::MYC is a
peripheral membrane protein.
We conducted a series of subcellular fractionation analyses
to determine the membrane compartment in which
RPM1::MYC resides. Numerous attempts to fractionate mem-
branes by linear or step sucrose gradients consistently sup-
ported the membrane-association of RPM1::MYC.
RPM1::MYC was found in fractions containing the endoplas-
mic reticulum (ER)-localized isoform of BiP (R. Boston,
personal communication) and a known PM marker, RD28 (16)
(Fig. 2C), but we were unable to define gradient conditions
that conclusively resolved PM and ER markers.
Therefore, we used aqueous two-phase partitioning to purify
vesicles enriched in PM (16). To verify enrichment of PM
vesicles, we sequentially reacted the same protein blot with
antibodies demonstrated previously to detect markers for
tonoplast (g-TIP; ref. 18), ER(BiP), and PM (RD28; ref. 16).
RD28 dimers (and monomers; not shown) were enriched in the
PM lane and g-TIP and BiP were absent, indicating substantial
PM enrichment with undetectable contamination by tonoplast
and ER vesicles (Fig. 2D). The continued presence of RD28 in
the intracellular membrane fraction is typical of vesicles made
with this protocol and reflects the occurrence of ‘‘outside-in’’
PM vesicles partitioning with the intracellular membrane
vesicles (19). Consistent with this, g-TIP and BiP were exclu-
sively detected in the intracellular membrane fraction.
RPM1::MYC, like RD28, is enriched in the PM vesicles (Fig.
2D), strongly suggesting that it is located in the PM.
RPM1::MYC Is Degraded at a Time Coincident with the
Onset of the HR. Previous work in our laboratory demon-
strated the endogenous RPM1 transcript level is not changed
after infection with avirulent P. syringae (M. Grant and J.L.D.,
unpublished data). Therefore, we wanted to determine
whether the expression profile or localization of the
RPM1::MYC protein was altered after infection. We moni-
tored RPM1::MYC expression over time in total protein
extracts from leaves inoculated with the virulent strain
DC3000 or with several avirulent DC3000 derivatives at a dose
of 5 3 107 cfuyml. Resistance to strains carrying avrRpm1 and
avrB is controlled by RPM1, which triggers a rapid HR with
tissue collapse at the infection site occurring '5 hpi. In
contrast, resistance to the strain carrying avrRpt2 is conferred
by a different LZ-NBS-LRR gene, RPS2, which triggers a
slower HR with tissue collapse occurring '22 hpi. Strikingly,
the level of RPM1::MYC expression declined sharply at a time
coincident with the onset of the HR produced by inoculation
with DC3000 carrying avrRpm1, avrB, or avrRpt2 (Fig. 3A). In
contrast to infection by avirulent strains, inoculation with
either virulent DC3000 (Fig. 3A) or MgCl2 buffer alone (not
FIG. 3. RPM1::MYC is degraded after inoculation with avirulent
P. syringae isolates, which trigger LZ-NBS-LRR resistance genes. (A)
Each panel represents infection of RPM1::MYC transgenics with P.
syringae DC3000 expressing a particular avirulence gene or not (thin
line) listed at left. Tissue was harvested at the time, in hpi listed at the
top, and total protein blots were probed with either anti-c-Myc
monoclonal or (B) marker proteins for various subcellular compart-
ments listed at the bottom of each series of blots in B. Extract from
control plants (vector) are included for anti-c-Myc and anti-BiP
experiments. The arrow marks RPM1::MYC in A. Star (p) represent
earliest time point where visible RPM1-dependent HR was observed,
and ampersand (@) represents the earliest time point where RPS2-
dependent HR was observed. This set of data is all from one set of
extracts and the experiment was repeated three times.
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shown) did not result in an HR or degradation of
RPM1::MYC. In fact, RPM1::MYC persisted even after the
initiation of chlorotic disease symptoms caused by DC3000
infection (22 hpi; Fig. 3A). We did not observe the appearance
of a low molecular weight carboxyl-terminal RPM1::MYC
fragment (down to '20 kDa) in any of our experiments.
We addressed whether the RPM1::MYC disappearance
reflected wholesale protein degradation at the onset of HR.
Fig. 3B demonstrates that it did not. Marker antigens for
cytoplasmic, ER, and tonoplast proteins are intact until well
beyond the onset of either RPM1- or RPS2-dependent HR or
onset of DC3000 disease symptoms. Whereas monomers and
dimers of the PM protein RD28 do begin to disappear at time
points when tissue collapse resulting from the HR is complete
and the tissue dry, this is later than the time when
RPM1::MYC is completely gone. We observed a similar slow
decline in the amounts of a PM-localized ATPase (data not
shown), suggesting that subsequent to RPM1::MYC disap-
pearance, degradation of PM proteins in general begins. The
disappearance of RPM1::MYC is not a peculiarity of the c-Myc
epitope, since another protein tagged by a carboxyl-terminal
c-Myc epitope, cytosolic AtPEP12p (gift from N. Raikhel), is
not lost during this time course (data not shown). Taken
together, these results suggest that the loss of RPM1::MYC
signal is not the result of random large-scale protein degra-
dation resulting from HR. We also monitored the localization
of RPM1::MYC over time after inoculation with
DC3000(avrRpm1) and found it to remain associated with the
membrane fraction as long as it could be detected (data not
shown).
Finally, in light of recent demonstrations that LZ-NBS-LRR
class R proteins can differ from TIR-NBS-LRR R proteins in
their genetic requirements for function (20), we asked whether
RPM1::MYC disappearance could be triggered by DC3000
carrying avrRps4. This P. syringae gene is recognized by the
TIR-NBS-LRR gene, RPS4, resulting in HR at roughly 20 hpi
(ref. 21; B. Staskawicz, personal communication). Fig. 4
demonstrates that RPM1::MYC also disappears at the time of
RPS4-mediated HR.
DISCUSSION
Localization of the RPM1::MYC Protein. We expressed a
fully functional c-Myc-tagged RPM1 protein in transgenic
Arabidopsis. The protein could be immunoprecipitated from
whole leaf extracts by two antibodies raised against nonover-
lapping domains of RPM1 and also identified directly on
protein blots by the anti-c-Myc antibody. Contrary to predic-
tion, the RPM1::MYC protein was not soluble, but rather
associated wholly with the microsomal membrane pellet, from
which it could be solubilized by treatments known to remove
peripheral membrane proteins. Furthermore, membrane frac-
tionation by aqueous two-phase partitioning demonstrated
that RPM1::MYC is enriched in PM vesicles in a manner
equivalent to a known PM marker protein. We conclude that
RPM1::MYC is a peripheral membrane protein and that a
significant portion of it is localized to the PM. Because the
RPM1::MYC protein was fully functional and expressed from
the native RPM1 promoter, its localization should closely
parallel that of the endogenous RPM1 protein.
Is the avr Signal Recognized by a Plasma Membrane-
Anchored Receptor Complex? Delivery of avr function to plant
cells requires the type III (hrp) secretion system. This system
is thought to deliver a variety of molecules, including virulence
and avirulence factors, directly into the host cells, as demon-
strated for a variety of bacterial pathogens of animals (22, 23).
In support of this hypothesis, expression of several avr gene
products in the host cell, either stably or transiently, has been
shown to be sufficient to trigger a resistance-like response (3,
5, 6). Bacterial type III secretion is thought to proceed through
the development of a pilus-like structure connecting the
pathogen and host cell (24). Therefore, localization of RPM1
to the cytoplasmic face of the PM may be advantageous in
placing the R gene product in a position to intercept incoming
pathogen-derived signals.
Whereas RPM1 does not contain a predicted transmem-
brane segment or signal peptide, our data demonstrate that it
is membrane localized and solubilized by treatments known to
not disrupt the structure of the lipid bilayer. Therefore, its
association with the membrane is likely maintained through
interactions with unidentified integral membrane proteins.
This finding is not inconsistent with published results using a
dog pancreas microsome import assay, which demonstrated
that RPS2 protein is not secreted or inserted into the lipid
bilayer (3). One candidate RPM1-tethering protein is the
product of the recently cloned NDR1 gene. NDR1 is required
for the function of a number of Arabidopsis R genes, including
RPM1, and is predicted to encode a small novel protein
containing two putative transmembrane segments (25). We
identified a second potential membrane anchor using the
N-terminal portion of RPM1 as bait in a yeast two-hybrid
screen. The N terminus of this protein contains six to seven
potential transmembrane segments and a novel carboxyl-
terminal cytoplasmic domain that interacts with RPM1
(D.C.B., S. Kaufman, and J.L.D., unpublished data).
The genetically defined specificity of avr recognition cou-
pled with recent findings that avr proteins are able to generate
R-dependent resistance-like responses when expressed inside
plant cells suggests that RPM1 and other NBS-LRR proteins
are receptors that directly interact with their cognate avr gene
products. Nevertheless, we have not been able to demonstrate
an RPM1 interaction with avrRpm1 or avrB through yeast
two-hybrid analysis (D.C.B. and J.L.D., unpublished work). In
contrast, the product of the tomato R gene Pto, which encodes
a serineythreonine protein kinase, has been shown to interact
with the avrPto protein of P. syringae (26, 27). Pto function also
requires the NBS-LRR protein Prf (28), although the bio-
chemical role that Prf plays in the response is unknown. By
analogy, RPM1 may not be sufficient to directly perceive the
avr signal, and a Pto-like kinase andyor additional factors may
be required to facilitate avr signal recognition. We have
additionally demonstrated that avrRpm1 and avrB proteins are
localized to plant cell plasma membranes and that this local-
ization is required for avirulence function (Z. Nimchuk, E.
Marois, S. Kjemtrup & J.L.D., unpublished work). Based on
the PM localization data we have presented for RPM1, we
speculate that additional factors required for RPM1 function
will be membrane localized as well. In support of this hypoth-
esis, Pto is predicted to have an N-terminal myristolation motif
and may therefore be targeted to the membrane. Indeed, the
Fen kinase of tomato, which is closely related to Pto and is also
Prf dependent, requires a consensus myristolation sequence
for function (29).
Degradation of RPM1::MYC May Define a Negative Feed-
back Loop That Controls the Extent of Response at the Site of
Infection. RPM1::MYC protein disappears rapidly at a time
FIG. 4. RPM1::MYC is degraded after inoculation with an aviru-
lent P. syringae isolate, which triggers a TIR-NBS-LRR resistance
gene. Experimental design is as in Fig. 3, but the time course is
extended to 40 hpi, at which time all proteins begin to degrade because
of disease (DC3000) or complete HR. Star (p) marks time point of
RPS4-dependent HR and arrows denote RPM1::MYC.
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coincident with initiation of the HR generated in response to
infection by P. syringae DC3000 carrying either avrRpm1, avrB,
avrRpt2, or avrRps4 (Figs. 3 and 4). In contrast, little or no loss
of RPM1::MYC is seen at corresponding time points in control
treatments that fail to produce an HR or after infection by
virulent DC3000. This is true even in leaves exhibiting the
onset of disease symptoms, indicating that cell death alone is
not sufficient for the initial rapid loss of RPM1::MYC to occur.
The disappearance of RPM1::MYC signal is most likely the
result of increased proteolytic activity. However, the rate of
RPM1::MYC turnover is unknown, and a rapid decrease in the
rate of RPM1::MYC translation could produce a similar result
and therefore cannot be ruled out.
At least two other PM proteins degrade subsequent to
RPM1::MYC disappearance and the onset of HR. This sug-
gests that loss of PM integrity is a major cellular event after
initial onset of HR. This is consistent with a variety of
microscopic analyses (ref. 30) showing that irreversible PM
damage is an early sign of HR. In this regard, our results are
inconsistent with the canonical early cellular events of animal
apoptosis, in which PM integrity is maintained until very late
in the cell death process. We also note that at prolonged time
points, all proteins assayed, regardless of cellular compart-
ment, disappear as disease develops in DC3000 inoculated
tissue (data not shown).
Degradation of RPM1 may be one way in which the cell is
able to control HR lesion size and response amplitude at the
site of infection. The timing of RPM1::MYC degradation at
the onset of HR is consistent with this idea. The alternative
hypothesis, that RPM1::MYC degradation serves a positive
signaling role, is less likely. If this were true, RPM1::MYC
degradation would occur much earlier in the response, before
or concurrent with the molecular and physiological changes
that promote defense gene activation (31, 32). It is intriguing
that RPM1::MYC is degraded after activation with
DC3000(avrRpm1 or avrB) by inoculation of
DC3000(avrRpt2), which activates RPS2, another LZ-NBS-
LRR protein, and by DC3000(avrRps4), which activates the
TIR-NBS-LRR protein RPS4. If these R gene pathways are
activated independently, then the mechanism targeting
RPM1::MYC for degradation is likely a general one that
degrades engaged as well as unengaged NBS-LRR proteins.
This phenomenon is also interesting in light of the recent
characterization of the Arabidopsis LSD1 gene (33, 34). Plants
carrying a deleted lsd1 allele exhibit spreading necrotic lesions,
suggesting that one function of the wild-type gene is to limit the
size of the HR. It will be of interest to determine whether the
RPM1::MYC degradation phenomenon will occur in an lsd1
background or in other Arabidopsis mutants that effect disease
resistance.
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